Citigroup Inc Hillstream Bio Pharma Inc. Transaction History

Citigroup Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$0.67 - $1.51 $84 - $190	-126 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.16 - $4.1 $146 - $516	126 New	126 $0

Ticker HILS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,529,900
Market Cap $33.2M
Description
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.